National Comprehensive Cancer Network



About NCCN

Prostate Cancer Panel - Disclosures as of 1/3/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict

Andrew J. Armstrong, MD, ScM

None

Amgen Inc.;
Bristol-Myers Squibb Company;
Dendreon Corporation;
Dendreon Corporation;
Johnson & Johnson;
Ipsen;
sanofi-aventis U.S.;
sanofi-aventis U.S.

None

None

None

Robert R. Bahnson, MD

None

Aveo Pharmaceuticals;
Young,Ricchiuti,Caldwell, and Heller,LLC

None

None

None

Michael Cohen, MD

None

LivingstonBarger;
Otorowski, et al.;
Simmons Perrine et al.

None

None

None

Anthony Victor D'Amico, MD, PhD

None

None

None

None

None

James A. Eastham, MD

None

None

None

None

None

Charles A. Enke, MD

None

None

None

None

None

Thomas A. Farrington, BSEE

None

None

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Celestia S. Higano, MD, FACP

None

Amgen Inc.;
Bayer HealthCare;
Dendreon Corporation;
Millennium Pharmaceuticals, Inc.;
Medivation

None

None

None

Maria Ho, PhD

None

None

None

None

None

Eric Mark Horwitz, MD

None

None

None

None

None

Philip W. Kantoff, MD

None

Bayer HealthCare;
Dendreon Corporation;
Jannsen Pharmaceutica Products, LP;
Bavarian Nordic Immunotherapy (BN-IT);
Tokai

None

None

None

Mark H. Kawachi, MD

None

None

None

None

None

Michael R. Kuettel, MD, MBA, PhD

None

None

None

None

None

Richard J. Lee, MD, PhD

None

None

None

None

None

Gary R. MacVicar, MD

None

Dendreon Corporation;
Jannsen Pharmaceutica Products, LP;
sanofi-aventis U.S.

None

None

None

Arnold W. Malcolm, MD, FACR

None

None

None

None

None

Joan S. McClure, MS

None

None

None

None

None

David Miller, MD, MPH

Blue Cross Blue Shield of Michigan

UnitedHealthcare

None

None

None

James L. Mohler, MD

None

None

None

Androbiosys, Inc.

None

Elizabeth R. Plimack, MD, MS

None

Amgen Inc.

None

None

None

Julio M. Pow-Sang, MD

None

Myriad Genetic Laboratories, Inc.

None

None

None

Sylvia Richey, MD

None

sanofi-aventis U.S.

None

None

None

Mack Roach III, MD

None

Ferring Pharma

None

None

None

Eric Rohren, MD, PhD

None

None

None

None

None

Stan Rosenfeld

None

None

None

None

None

Dorothy Shead, MS

None

None

None

None

None

Eric J. Small, MD

None

Dendreon Corporation

None

None

None

Guru Sonpavde, MD

None

Amgen Inc.;
Dendreon Corporation;
Jannsen Pharmaceutica Products, LP;
sanofi-aventis U.S.

None

None

None

Sandy Srinivas, MD

None

Medivation

None

None

None

Cy Stein, MD, PhD

None

Amgen Inc.;
Jannsen Pharmaceutica Products, LP;
sanofi-aventis U.S.

None

None

None

Seth A. Strope, MD, MPH

None

None

None

None

None

Jonathan Tward, MD, PhD

None

Myriad Genetic Laboratories, Inc.

None

None

None

Patrick C. Walsh, MD

None

None

None

None

None